youtube_live
Q3 2026 earnings • released • EPS beat +8.31% • Revenue beat +1.34%
See resultschevron_right
DXCM:NASDAQ
DexCom Inc
$84.76
arrow_upward
+3.00%(+2.47) 1D
$85.05
arrow_upward
+0.34% (+0.29)todayPre-market
Closed: Nov 2, 4:00:01 PM GMT-5 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DXCM...
Open
$82.94
High
$85.20
Low
$82.52
Mkt. cap
31.61B
Avg. vol.
4.30M
Volume
676.00
P/E ratio
33.30
52-wk high
$92.59
52-wk low
$54.11
EPS
$2.55
Beta
1.48
Shares outstanding
372.95M
No. of employees
11K
Open
$82.94
High
$85.20
Low
$82.52
Mkt. cap
31.61B
Avg. vol.
4.30M
Volume
676.00
P/E ratio
33.30
52-wk high
$92.59
52-wk low
$54.11
EPS
$2.55
Beta
1.48
Shares outstanding
372.95M
No. of employees
11K
News stories
From web sources and news partners
News Corp
·
12 hours ago
DexCom Inc. stock underperforms Monday when compared to competitors despite daily gains
HME News
·
17 hours ago
Dexcom invites diabetes community to share their journey with the disease
Rutland Herald
·
20 hours ago
Dexcom Invites the Global Diabetes Community to Share Their Stories Through A Letter to Diabetes Campaign
Yahoo Finance
·
21 hours ago
Dexcom lifts 2026 revenue outlook after positive Q3
Profile
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland. Wikipedia
About DexCom Inc
CEO-
Employees11K
Founded1999
HeadquartersSan Diego, California, United States
SectorMedical device
Websitedexcom.com
Analyst ratings
Based on 17 analysts giving stock ratings to DXCM in the past 3 months
Strong buy
Buy
16
Hold
1
Sell
0
12-month forecast
Based on 17 Wall Street analysts offering 12 month price targets for DXCM in the last 3 months.
Highest
Current $84.76
$120.00 (+41.58%)
Average
$99.56 (+17.46%)
Lowest
$85.00 (+0.28%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Unknown Analyst Leerink Partners | Buy | Maintained | $94.00 | +10.9% | 11/02/2026 |
Robbie Marcus J.P. Morgan | Hold | Reiterated | $85.00 | +0.3% | 10/30/2026 |
Jonathan Block Stifel Nicolaus | Buy | Reiterated | $95.00 | +12.1% | 10/30/2026 |
Josh Jennings TD Cowen | Buy | Reiterated | $95.00 | +12.1% | 10/30/2026 |
Jayson Bedford Raymond James | Buy | Maintained | $97.00 | +14.4% | 10/30/2026 |
Unknown Analyst Evercore ISI | Buy | Maintained | $110.00 | +29.8% | 10/30/2026 |
Danielle Antalffy UBS | Buy | Reiterated | $107.00 | +26.2% | 10/30/2026 |
Kendall Au RBC Capital | Buy | Maintained | $105.00 | +23.9% | 10/29/2026 |
Matthew O'Brien Piper Sandler | Buy | Reiterated | $95.00 | +12.1% | 10/30/2026 |
William Plovanic Canaccord Genuity | Buy | Reiterated | $97.00 | +14.4% | 10/30/2026 |
Christopher Pasquale Barclays | Buy | Maintained | $120.00 | +41.6% | 10/30/2026 |
Patrick Wood UBS | Buy | Maintained | $107.00 | +26.2% | 10/30/2026 |
Travis Steed Bank of America Securities | Buy | Maintained | - | - | 10/23/2026 |
Joanne Wuensch Citi | Buy | Maintained | $105.00 | +23.9% | 10/21/2026 |
Larry Biegelsen Wells Fargo | Buy | Maintained | $90.00 | +6.2% | 10/14/2026 |
Anthony Petrone Mizuho Securities | Buy | Reiterated | $100.00 | +18% | 10/13/2026 |
Ryan Zimmerman BTIG | Buy | Maintained | $96.00 | +13.3% | 10/12/2026 |
Marie Thibault BTIG | Buy | Maintained | $96.00 | +13.3% | 10/12/2026 |
Matt Miksic Barclays | Buy | Maintained | $115.00 | +35.7% | 10/07/2026 |
Shagun Singh Chadha RBC Capital | Buy | Maintained | $105.00 | +23.9% | 10/01/2026 |
Richard Newitter Truist Financial | Buy | Maintained | $102.00 | +20.3% | 09/23/2026 |
Steven Silver Argus Research | Buy | Maintained | $96.00 | +13.3% | 08/03/2026 |
Steven Lichtman William Blair | Buy | Maintained | - | - | 07/31/2026 |
Kieran Ryan Deutsche Bank | Buy | Reiterated | $92.00 | +8.5% | 07/31/2026 |
Bruce Jackson StoneX | Buy | Maintained | $82.00 | -3.3% | 07/31/2026 |
Jeff Johnson Robert W. Baird | Buy | Maintained | $105.00 | +23.9% | 07/31/2026 |
Unknown Analyst Deutsche Bank | Buy | Initiated | $86.00 | +1.5% | 06/25/2026 |
David Roman Goldman Sachs | Buy | Maintained | $80.00 | -5.6% | 05/15/2026 |
Unknown Analyst Stifel Nicolaus | Buy | Maintained | $85.00 | +0.3% | 05/15/2026 |
Lee Hambright Bernstein | Buy | Maintained | $77.00 | -9.2% | 05/15/2026 |
Unknown Analyst Jefferies | Buy | Maintained | $112.00 | +32.1% | 05/14/2026 |
Unknown Analyst Argus Research | Buy | Maintained | $86.00 | +1.5% | 05/05/2026 |
Brandon Vazquez William Blair | Buy | Maintained | $59.00 | -30.4% | 05/01/2026 |
Suraj Kalia Oppenheimer | Hold | Reiterated | - | - | 02/13/2026 |
Last report
Oct 29, 2026
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
$0.73 / $0.67
+8.31%beat
arrow_upward
Revenue / Est. (USD)
1.34B / 1.33B
+1.34%beat
arrow_upward
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
Revenue | 1.26B | 1.19B | 1.31B | 1.34B |
Cost of goods sold | 466.90M | 441.60M | 478.40M | 480.10M |
Cost of revenue | 466.90M | 441.60M | 478.40M | 480.10M |
Research and development expenses | 148.20M | 145.30M | 153.00M | 161.60M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 321.50M | 349.70M | 358.70M | 375.60M |
Operating expense | 469.70M | 495.00M | 511.70M | 537.20M |
Total operating expenses | 936.60M | 936.60M | 990.10M | 1.02B |
Operating income | 323.00M | 255.30M | 318.30M | 327.20M |
Other non operating income | -1.60M | -2.20M | -4.70M | -3.70M |
EBT including unusual items | 340.70M | 269.50M | 317.50M | 334.70M |
EBT excluding unusual items | 340.70M | 269.50M | 327.50M | 334.70M |
Income tax expense | 73.40M | 70.00M | 68.40M | 59.60M |
Effective tax rate | 21.54% | 25.97% | 21.54% | 17.81% |
Other operating expenses | - | - | - | - |
Net income | 267.30M | 199.50M | 249.10M | 275.10M |
Net profit margin | 21.22% | 16.74% | 19.04% | 20.46% |
Earnings per share | 0.68 | 0.56 | 0.70 | 0.73 |
Interest and investment income | 23.50M | 19.50M | 16.90M | 14.30M |
Interest expense | -4.20M | -3.10M | -3.00M | -3.10M |
Net interest expenses | 19.30M | 16.40M | 13.90M | 11.20M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 388.20M | 322.40M | 386.50M | 401.70M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events